Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment (Q83533316)
Jump to navigation
Jump to search
scientific article published on 28 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment |
scientific article published on 28 February 2012 |
Statements
Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment (English)
Hanne Fredly
Håkon Reikvam
Oystein Bruserud
28 February 2012